Overview:
FDA
inspections and audits continue to put a bright spotlight on data
integrity—especially when organizations rely on tools like Excel to create,
calculate, analyze, transfer, or report GxP data. When a spreadsheet influences
product quality decisions or regulated records, it can effectively function as
a GxP system, and it must be supported by a validation approach that is
defendable, risk-based, and inspection-ready.
In
this webinar, we’ll walk through a practical, risk-based method for evaluating
Excel spreadsheet applications used in FDA-regulated activities and determining
the impact of failure on data integrity, process performance, product quality,
and patient/consumer safety. You’ll learn how to apply SDLC principles to
spreadsheet applications—starting with risk assessment and requirements
definition, then moving through streamlined validation planning, testing,
documentation, and lifecycle maintenance.
We’ll
also clarify how Excel fits within common validation frameworks (including GAMP
5 concepts). For example, a standard installation may be treated differently
than a spreadsheet that includes macros or other custom functionality, which
increases risk and elevates validation expectations. The session will cover how
to plan and execute validation activities—such as IQ/OQ-style evidence where
appropriate—while still keeping the effort efficient and focused on proving
that the spreadsheet application meets its intended use.
Finally,
we’ll connect validation strategy to 21 CFR Part 11 expectations and broader
data integrity controls, including the documentation, policies, procedures, and
operational practices needed to keep spreadsheet applications in a validated
state over time—and to be ready for FDA inspection questions with confidence.
Areas
covered in the session:
This webinar includes the following key objectives:
- Learn
how to identify spreadsheet applications that are considered to be “GxP”
Systems
- Discuss
the Computer System Validation (CSV) approach based on FDA requirements to
ensure a spreadsheet application will meet requirements and will be suitable
for its intended task(s)
- Learn
about Computer Software Assurance (CSA) and how this approach may streamline
your validation work
- Learn
about the System Development Life Cycle (SDLC) approach to validation, and how
to apply this to Excel spreadsheet applications
- Discuss
the best practices for documenting computer system validation efforts for
spreadsheet applications, including requirements, design, development, testing
and operational maintenance procedures
- Understand
how to maintain a spreadsheet application in a validated state through the
system’s entire life cycle
- Learn
how to assure the integrity of data that supports GxP work done using the
spreadsheet application
- Learn
about the policies and procedures needed to support your validation process and
ongoing maintenance of your systems in a validated state
- Understand
the key components of 21 CFR Part 11 compliance for electronic records and
signatures
- Know
the regulatory influences that lead to FDA’s current thinking at any given time
- Learn
how to conduct a risk assessment on a spreadsheet application that will provide
the basis for developing a validation rationale
- Learn
how to best prepare for an FDA inspection or audit of a GxP spreadsheet
application
- Finally,
understand the industry best practices that will enable you to optimize your
approach to validating spreadsheet applications, based on risk assessment, to
ensure data integrity is maintained throughout the entire data life cycle
- Q&A
Why
Should You Attend?
Excel
is still one of the most common tools used to support GxP work—yet it’s also
one of the easiest places for data integrity and validation gaps to form. If
your organization relies on spreadsheets for regulated activities, you need a
clear, defensible approach to determine when a spreadsheet becomes a GxP
system, what the real risk is, and what evidence FDA will expect to see during
an inspection.
This
session helps you move from uncertainty and inconsistent practices to a
structured, risk-based validation strategy. You’ll learn how to apply SDLC
thinking to spreadsheet applications—defining requirements, planning and
executing efficient testing, and documenting what matters—so your validation
effort is thorough without becoming overly burdensome.
You’ll also walk away with practical guidance on maintaining spreadsheet applications in a validated state over their lifecycle, aligning your approach with 21 CFR Part 11 expectations and current regulatory focus on data integrity. The result: stronger inspection readiness, clearer internal justification for your validation decisions, and a more reliable foundation for GxP data and product quality decisions.
Handouts:
Attendees will gain access to exclusive handouts, including presentation materials provided by the speaker and additional resources developed by Amorit Education to aid your teams in post-session implementation, such as:
- GxP Spreadsheet Validation Decision Kit (PDF)
- Streamlined SDLC Validation Pack for Excel Spreadsheet Applications (PDF)
Industries
that will benefit from this training:
Manufacturing,
Testing, Packaging and Distribution companies in the following industries that
are regulated by FDA are required to follow GxPs:
- Pharmaceutical
(for drug products introduced using a medical device)
- Medical
Device
- Biologicals
(for biological products introduced using a medical device)
- Tobacco
(based on the Tobacco Control Act of 2009)
- E-Liquid/Vapor
(based on the “Deeming” Act of 2016)
- E-Cigarette
(based on the “Deeming” Act of 2016)
- Cigar
(based on the “Deeming” Act of 2016)
- Third-Party
companies that support those in the above industries, including Contract
Research Organizations (CROs)
- Colleges
and Universities offering programs of study in Clinical Trial Management and
Regulatory Affairs/Matters related to FDA
Who
will benefit?
Personnel
in the following roles will benefit:
- Information
Technology (IT) developers, testers, support resources
- QC/QA
Managers
- QC/QA
Analysts
- Clinical
Data Managers
- Clinical
Data Scientists
- Analytical
Chemists
- Compliance
Managers
- Laboratory
Managers
- Automation
Analysts
- Manufacturing
Managers
- Manufacturing
Supervisors
- Supply
Chain Specialists
- Computer
System Validation Specialists
- GMP
Training Specialists
- Business
Stakeholders responsible for computer system validation planning, execution,
reporting, compliance, maintenance and audit
- Consultants
working in the life sciences industry who are involved in computer system
implementation, validation and compliance
- Auditors
engaged in the internal inspection of labeling records and practices
Carolyn Troiano has more than 40 years of experience in computer system validation in the pharmaceutical, medical device, animal health, tobacco and other FDA-regulated industries. She is currently an independent consultant, advising companies on computer system validation and large-scale IT system implementation projects.
During her career, Carolyn worked directly, or on a consulting basis, for many of the larger pharmaceutical companies in the US and Europe. She developed validation programs and strategies back in the mid-1980s, when the first FDA guidebook was published on the subject, and collaborated with FDA and other industry representatives on 21 CFR Part 11, the FDA’s electronic record/electronic signature regulation
Carolyn has participated in industry conferences. She is currently active in the PMI, AITP, and RichTech, and volunteers for the PMI’s Educational Fund as a project management instructor for non-profit organizations.
Enrollment Options
Tags: Excel spreadsheet validation, GxP compliance, FDA audits, CSV training, CSA approach, SDLC validation, data integrity, 21 CFR Part 11, electronic records & signatures, risk-based validation, GAMP 5, inspection readiness, validation documentation, IQ/OQ guidance, regulated systems, carolyn troiano, january 2026. webinar

